Emerging research has provided fresh evidence regarding the role of viral infection in the development of multiple sclerosis.

Try these tiny mood boosts that take less time than a coffee break.

Our world is a rich tapestry of sensory information, constantly bombarding our nervous system with a vast array of stimuli. How does the brain make sense of ...

Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...

It’s been spruiked as everything from cutting-edge science to an unethical wasteland masquerading as healthcare.

Allschwil, Switzerland - February 06, 2026Idorsia Ltd (SIX: IDIA) announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker ...

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...